3 Types of Risks Facing Biotech Stocks
Biotech stocks have been dramatically outperforming the broader market, but that doesn't mean they're free of risk. Here are three types of risks all biotech stocks face.
Could This Tiny Biotech Be on Gilead Sciences’ M&A Radar?
Gilead Sciences is on the the prowl for potential buyout targets. This little-known immuno-therapy company looks like a perfect match for the biotech in many ways. Here's why.